Portfolio company
3SBio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops and manufactures recombinant protein products for patients with oncology, nephrology, immunology, and autoimmune diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
D3 Bio
This biotechnology company develops precision medicines and oncology therapeutics for patients with cancer and immunological conditions.
Protuoso Biosciences
This company develops multifunctional recombinant fusion proteins for pharmaceutical researchers and clinicians treating cardiometabolic, oncological and autoimmune diseases.
Clinical-stage biotech
This company develops immunomodulatory recombinant protein therapies to treat autoimmune and chronic inflammatory diseases for patients with conditions such as chronic inflammatory demyelinating polyneuropathy.
Reverb Therapeutics
This biotechnology company develops bispecific antibody therapies that redirect the body's natural cytokines to treat patients with cancer and autoimmune diseases.
Clim Bio
This biotechnology company develops antibody-based medicines for patients with immune-mediated diseases such as lupus and IgA nephropathy.
Alpine Immune Sciences
This biopharmaceutical company develops protein-based immunotherapies to treat autoimmune and inflammatory diseases for patients with conditions like kidney disease.
Everest Medicines
This biopharmaceutical company develops and commercialises therapeutic products and vaccines to treat patients with unmet medical needs in Asia and global markets.
Amgen
This biotechnology company develops and manufactures biologic medicines to treat patients with serious illnesses, including cancer, kidney disease and inflammatory disorders.
